Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Relief Therapeutics

Relief Therapeutics
2013 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
RLF STOCK SYMBOL
1 INVESTMENTS
Description

Relief Therapeutics Holding AG is a Switzerland based drug development company focusing on clinical stage projects, primarily developing drugs of natural human origin. It is engaged in its operations for diabetic complications and respiratory diseases. The company is focused on developing drug candidates namely, Aviptadil and Atexakin alfa. Aviptadil is a biologically active endogenous human peptide that possesses anti-proliferative, anti-inflammatory, and immune regulatory activities. Atexakin alfa is a low dosage formulation of interleukin-6 that exhibits functions in diverse tissues and organs. The group operates its functions in Switzerland.

Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
SWX
Primary Office
  • Fondation EIP, Batiment F2/F3
  • Avenue de S├ęcheron 15
  • 1202 Geneva
  • Switzerland
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Relief Therapeutics’s full profile, request a free trial.

Relief Therapeutics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.12M 3.39M 2.11B

Relief Therapeutics Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 10,740 11,931 20,443 22,638
Revenue 568 577 0 0
EBITDA (373) (265) (1,838) (17)
Net Income (630) (446) (2,932) (17)
Total Assets 31,777 36,135 31,795 30,843
Total Debt 1,411 5,449 1,039 862
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Relief Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Relief Therapeutics‘s full profile, request access.

Request full access to PitchBook

Relief Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 000000 27-Jul-2016 000000000000000000 Drug Discovery
To view this company’s complete investment and acquisition history, request access »

Relief Therapeutics Subsidiaries (1)

Company Name Industry Location Founded
00000000000 000000 Drug Discovery Mount Pleasan, SC 0000
To view this company’s complete subsidiary history, request access »

Relief Therapeutics Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Relief Therapeutics‘s full profile, request access.

Request full access to PitchBook

Relief Therapeutics Executive Team (5)

Name Title Board
Seat
Contact
Info
Yves Sagot Ph.D Chief Scientific Officer & Co-Founder
Michel Dreano Ph.D Co-Founder, Board Member & Chief Operating Officer
Dorian Bevec Ph.D Chief Development Officer

2 Former Executives

You’re viewing 3 of 5 executives. Get the full list »

Relief Therapeutics Board Members (2)

Name Representing Role Since Contact
Info
00000 00 00000000 00 Global Emerging Markets Board Member 000 0000
00000000 000000000 00.0 Relief Therapeutics Chairman of the Board 000 0000